PREMD INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -.--% |
Financials (USD)
| Sales 2006 | 3.34 | Sales 2007 | 0.09 | Capitalization | 33.28M |
|---|---|---|---|---|---|
| Net income 2006 | -5M | Net income 2007 | -6M | EV / Sales 2006 | 11,468,067 x |
| Net Debt 2006 | 3.07M | Net Debt 2007 | 4.44M | EV / Sales 2007 | 399,046,792 x |
| P/E ratio 2006 |
-5.86
x | P/E ratio 2007 |
-5.08
x | Employees | - |
| Yield 2006 * |
-
| Yield 2007 |
-
| Free-Float | 70.7% |
More Fundamentals
* Assessed data
| Managers | Title | Age | Since |
|---|---|---|---|
H. Norton
FOU | Founder | 63 | 92-11-08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
H. Norton
FOU | Founder | 63 | 92-11-08 |
PreMD Inc is a Canada-based medical device company. The Company is engaged in the development and sale of non-invasive tests that detect early stage cardiovascular diseases and cancers. The Companyâs products include PREVU Skin Sterol Test, ColorectAlert, LungAlert and Breast Cancer Test. The Company's PREVU Skin Sterol Test is a simple, non-invasive skin cholesterol test that is used in the determination of the risk assessment of coronary artery disease (CAD). The Companyâs ColorectAlert is a screening test for colorectal cancer. LungAler is a screening test for colorectal cancer. Breast Cancer Test is a screening test for breast cancer. In addition to this, the Company has a number of products in its pipeline, which are in various stages of development. The products include the Color Measurement product, Other Cancers product, Colopath and the Genomics products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 38 | |
| +19.79% | 42.78B | |
| +18.59% | 22.25B | |
| +13.12% | 14.39B | |
| +12.12% | 13.55B | |
| +35.83% | 11.27B | |
| -9.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.29% | 5.01B |
- Stock Market
- Equities
- PREMF Stock
